Evidence map›Paper›PMID 42097651›Full record

ArticleBMJ open2026

Preparing healthcare providers to use polygenic risk scores: a qualitative study of learning needs and educational preferences.

Amy Clark, Courtney K Wallingford, Jennifer Berkman, Aideen McInerney-Leo, Amy Nisselle, Bronwyn Terrill, Nathan Palpant, Mary-Anne Young, Paul A James, Tatiane Yanes

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amy Clark *Dermatology Research Centre, Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-8695-5750
Courtney K Wallingford *Dermatology Research Centre, Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia.
Jennifer BerkmanDermatology Research Centre, Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia.
Aideen McInerney-LeoDermatology Research Centre, Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-0059-5732
Amy NisselleMurdoch Childrens Research Institute, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0002-8908-5906
Bronwyn TerrillClinical Translational and Engagement Platform, Garvan Institute of Medical Research, Sydney, South Australia, Australia.
Nathan PalpantDermatology Research Centre, Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia.
Mary-Anne YoungClinical Translational and Engagement Platform, Garvan Institute of Medical Research, Sydney, South Australia, Australia.
Paul A JamesParkville Familial Cancer Centre, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0002-4361-4657
Tatiane YanesDermatology Research Centre, Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia t.yanes@uq.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPolygenic risk scores are increasingly available to consumers to provide an estimate of the genetic contribution to health conditions. However, healthcare providers report limited knowledge and confidence using polygenic risk scores. Clinical implementation necessitates educational programmes to support clinicians to integrate this new test into practice. This study aimed to identify healthcare providers' learning needs and preferences for polygenic risk education to inform the design of tailored education initiatives. DESIGN, SETTING AND

participantsThis pragmatic qualitative study used focus groups to capture healthcare providers' perspectives. To ensure informed responses, genetic healthcare providers with prior experience using polygenic risk scores, and/or who had completed polygenic risk education were recruited to participate in focus groups or interviews (n=30). There were no exclusions based on country of practice. Recordings were transcribed and content analysis conducted to identify learning needs. Themes related to education engagement were mapped to the capability, opportunity and motivation model for behaviour change.

resultsAmong this cohort of experienced providers, residual gaps existed in polygenic risk-related knowledge, skills and local guidelines to inform practice. Learning needs encompassed: (i) polygenic risk-specific knowledge, and (ii) communication skills needed to discuss results and facilitate risk management. Themes related to engaging with polygenic risk education mapped to capability included awareness of, and access to educational resources and initiatives, including practice resources and position statements from professional bodies. Time-poorness was a primary barrier to accessing education. Opportunities comprised of building on existing workplace training and activities such as multidisciplinary team meetings and journal clubs. All participants noted that motivation for completing polygenic risk training was primarily driven by a desire to improve patient-centred care and clinical outcomes.

conclusionThis study highlights priority learning areas to inform the development of tailored polygenic risk education initiatives, and resources and delivery strategies that meet the identified needs. Participants' expert insights reveal potential barriers as well as solutions to engaging healthcare providers with polygenic risk score education to ultimately facilitate implementation into clinical practice.

Indexed as

Health PersonnelMultifactorial InheritanceAdultFemaleFocus GroupsGenetic Risk ScoreHealth Knowledge, Attitudes, PracticeHumansQualitative ResearchEDUCATION & TRAINING (see Medical Education & Training)Genomic MedicineHealth Workforce

Identifiers

PMID42097651
PMCPMC13157732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.